Genetic testing to access genomics instability indicators in cancer cells to seek for possibility of using PARPi treatment
Suitable for
· Ovarian cancer patient with negative BRCA1/2 test outcome and seek for possibility using PARP inhibitor as treatment
Turn-Around Time (TAT)
· 26 Working Days
Sample Requirement
· 5 mL peripheral blood (EDTA tube)
· 10- 12 unstained FFPE
· 1X H&E section (controlled)
